Literature DB >> 14563544

Cause and manner of death in drug-related fatality: an analysis of drug-related deaths recorded by coroners in England and Wales in 2000.

Lucy Webb1, Adenekan Oyefeso, Fabrizio Schifano, Survjit Cheeta, Mike Pollard, A Hamid Ghodse.   

Abstract

This study investigated causes and manner of drug-related fatalities recorded in 2000 in the United Kingdom, measuring the 'masked' manner of death in cases typically recorded as overdose. A retrospective cohort study was used of 1037 cases of accidental drug-related fatalities reported by coroners in England and Wales to the National Programme of Substance Abuse Deaths. Whilst 802 cases were identified as direct acute overdose, representing 77% of the total accidental deaths, 23% of 'overdose' fatalities were caused by asphyxiation (7%), drug-related medical conditions (7%), non-drug-related conditions (4%), traumatic accidents (3%) and infections (2%). Younger people show higher risk of overdose and asphyxiation; older people show higher risk from pre-existing medical conditions. This study not only confirmed the high risk of overdose associated with heroin and polydrug use, but it also identified other high fatality risk factors for heroin/morphine users such as contracting an acute infection leading to septicaemia or endocarditis, or contracting a chronic infection such as HIV, HBV or HCV. In contrast, stimulants particularly featured in traumatic accidents, with amphetamine use most associated with cardio-vascular fatality. These findings highlight the 'masked' manner of death in cases commonly recorded as overdose and demonstrate the need for a more-detailed and systematic method of recording drug-related deaths in order to inform drug education and harm reduction strategies.

Entities:  

Mesh:

Year:  2003        PMID: 14563544     DOI: 10.1016/s0376-8716(03)00191-1

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  10 in total

1.  Mortality among young injection drug users in San Francisco: a 10-year follow-up of the UFO study.

Authors:  Jennifer L Evans; Judith I Tsui; Judith A Hahn; Peter J Davidson; Paula J Lum; Kimberly Page
Journal:  Am J Epidemiol       Date:  2012-01-06       Impact factor: 4.897

2.  Epidemiological findings and medical, legal, and public health challenges of an investigation of severe soft tissue infections and deaths among injecting drug users -- Ireland, 2000.

Authors:  K Murray-Lillibridge; J Barry; S Reagan; D O'flanagan; G Sayers; C Bergin; E Keenan; S O'briain; P Plunkett; G McMahon; C Keane; P O'sullivan; D Igoe; L Mullen; M Ward; A Smith; M Fischer
Journal:  Epidemiol Infect       Date:  2005-11-29       Impact factor: 2.451

Review 3.  A bitter pill. Overview of ecstasy (MDMA, MDA) related fatalities.

Authors:  Fabrizio Schifano
Journal:  Psychopharmacology (Berl)       Date:  2003-12-13       Impact factor: 4.530

4.  Circumstances and witness characteristics associated with overdose fatality.

Authors:  Amy S B Bohnert; Melissa Tracy; Sandro Galea
Journal:  Ann Emerg Med       Date:  2009-06-21       Impact factor: 5.721

5.  Predictors of opioid misuse in patients with chronic pain: a prospective cohort study.

Authors:  Timothy J Ives; Paul R Chelminski; Catherine A Hammett-Stabler; Robert M Malone; J Stephen Perhac; Nicholas M Potisek; Betsy Bryant Shilliday; Darren A DeWalt; Michael P Pignone
Journal:  BMC Health Serv Res       Date:  2006-04-04       Impact factor: 2.655

6.  A primary care, multi-disciplinary disease management program for opioid-treated patients with chronic non-cancer pain and a high burden of psychiatric comorbidity.

Authors:  Paul R Chelminski; Timothy J Ives; Katherine M Felix; Steven D Prakken; Thomas M Miller; J Stephen Perhac; Robert M Malone; Mary E Bryant; Darren A DeWalt; Michael P Pignone
Journal:  BMC Health Serv Res       Date:  2005-01-13       Impact factor: 2.655

7.  Mortality from treatable illnesses in marginally housed adults: a prospective cohort study.

Authors:  Andrea A Jones; Fidel Vila-Rodriguez; Olga Leonova; Verena Langheimer; Donna J Lang; Alasdair M Barr; Ric M Procyshyn; Geoffrey N Smith; Krista Schultz; Tari Buchanan; Michael Krausz; Julio S Montaner; G William MacEwan; Alexander Rauscher; William J Panenka; Allen E Thornton; William G Honer
Journal:  BMJ Open       Date:  2015-08-21       Impact factor: 2.692

8.  Analysis of psychotropic drug-related deaths in south Osaka.

Authors:  Naoto Tani; Tomoya Ikeda; Tomomi Michiue; Shigeki Oritani; Fumiya Morioka; Takaki Ishikawa
Journal:  Subst Abuse Rehabil       Date:  2018-09-24

9.  Problem drug use the public health imperative: what some of the literature says.

Authors:  Gez Bevan
Journal:  Subst Abuse Treat Prev Policy       Date:  2009-12-16

10.  'On the same level': facilitators' experiences running a drug user-led safer injecting education campaign.

Authors:  Cody Callon; Grant Charles; Rick Alexander; Will Small; Thomas Kerr
Journal:  Harm Reduct J       Date:  2013-03-06
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.